Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc
Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425
ID:1491159909794291720
https://www.dana-farber.org/breast-oncology-program/ 08-02-2022 21:20:39
4,0K Tweets
4,5K Followers
334 Following
Full house today at our #USCAP2024 symposium! Thank you Korentzelos Dimitris, Stuart Schnitt & Adam L. Booth, MD for making a strong case for using #AI in routine #pathology practice to help improve #cancer care. Dana-Farber WUSM Pathology & Immunology UPMC USCAP #digitalpathology #cancer diagnostics
Goodbye #USCAP2024 ! Thank you to the hundreds of visitors who came for a demo, chat & ☕ at the booth or clinical sessions & to the trailblazing researchers who made the case for deploying #AI in #patholgoy TODAY! Korentzelos Dimitris Stuart Schnitt Adam L. Booth, MD Zaibo Li USCAP
Young survivors of #BreastCancer face difficult decisions about their future #fertility beginning at the time of diagnosis. A study from Kimia Sorouri, MD, MPH et al explores post-cancer conception and pregnancy experiences for these survivors.
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
#IWD2024
What happens when #hereditarycancer testing identifies two pathogenic variants? We compared cancer risk in >600 individuals with double PVs to those with a single PV in this publication with Dana-Farber. hubs.ly/Q02qphlm0 #genechat #genechat pubs @nbagaglu Brittany Bychkovsky, MD
Our study at the Dana-Farber has been recently published in Genetics in Medicine Open! It is such a pleasure to be a member of the Dana-Farber Cancer Genetics&Prevention family and to work with the Ambry Genetics team! #hereditarycancer Carrie Horton Brittany Bychkovsky, MD Huma Rana, MD, MPH judy garber
🎉Congratulations to Dr. Nelly Polyak on her election to the esteemed American Academy of Arts and Sciences! Your contributions to academia and #CancerResearch are truly remarkable! Polyak Lab
Our CA: A Cancer Journal for Clinicians review on Agnostic ADCs among the top cited articles of 2022-2023! acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…
Paolo Tarantino 3. if a pt has progressive brain mets and you are planning a switch to an ADC anyways, strongly consider deferring RT to see if the ADC itself will exert intracranial activity - best way to avoid radionecrosis is to avoid RT when systemic tx is a reasonable option
Impressive intracranial activity of both T-DXd (65%) and T-DM1 (34%) for HER2+ brain metastases.
🎙️ Don’t miss the accompanying podcast, where G Curigliano MD PhD and I had the opportunity to interview Sara Hurvitz and Nancy Lin, MD to discuss the results.
Spotify Link: open.spotify.com/episode/2JO8wQ…
Antibody–drug conjugates are active in patients with HER2+ breast cancer brain metastases: where do we go from here? Read the editorial on the brain mets analysis from DB03 by Sarah Sammons (Dr Sarah Sammons) and Nancy Lin (@nlinmd) from Dana-Farber’s Breast Oncology Center. esmoopen.com/article/S2059-…
Out in ESMO Open the intracranial activity of T-DXd vs T-DM1 in the DESTINY-Breast03 phase 3 trial. Among patients with active brain mets, IC-ORR was 65.7% with T-DXd vs 34.3% with T-DM1. Accompanied by a podcast 🎙️ & an editorial by Dr Sarah Sammons Nancy Lin, MD. esmoopen.com/article/S2059-…
Insightful discussion on optimizing post neoadjuvant treatment in patients with early #BreastCancer achieving pathologic complete response in Journal of Clinical Oncology from Carmine Valenza Dario Trapani Sibylle Loibl #StephenChia Harold J. Burstein, MD, PhD, FASCO and G Curigliano MD PhD
Read it here👇
pubmed.ncbi.nlm.nih.gov/38569132/
The unmissable Harvard University breast cancer course is coming back on July 11-12, featuring a terrific faculty and a keynote lecture by Aleix Prat #PrecisionOncology. Make sure to join us, in person or virtually! cmecatalog.hms.harvard.edu/breast-cancer-…
Check out Dana-Farber’s recent Momentum article highlighting the #ETHANtrial , led by Jose Pablo Leone, MD, which is aimed at revolutionizing care for #MaleBreastCancer .
📍The trial is open at sites across the US. #BreastCancerInMen Translational Breast Cancer Research Consortium
More here👇
physicianresources.dana-farber.org/news/breast-ca…